Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells

Experimental Cell Research

Volumn 316, Issue 19, 2010, Pages 3161-3171

  Frame, Fiona M ^a,c   Hager, Stefanie ^a,c,d   Pellacani, Davide ^a   Stower, Mike J ^b   Walker, Hannah F ^a   Burns, Julie E ^a   Collins, Anne T ^a   Maitland, Norman J ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b YORK HOSPITAL   (United Kingdom)

^c Gene Bridges GmbH   (Germany)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Differentiation; Epithelial cells; Fluorescent proteins; Lentivirus; Prostate

Indexed keywords

BETA ACTIN; CD133 ANTIGEN; LENTIVIRUS VECTOR; PROBASIN; PROSTATE SPECIFIC ANTIGEN; PROSTATE STEM CELL ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ARTICLE; CELL ACTIVATION; CELL CLONE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA METHYLATION; EPITHELIUM CELL; GENE INSERTION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; CYTOLOGY; DNA SEQUENCE; FLUORESCENCE; GENE VECTOR; GENETIC PROCEDURES; GENETICS; LENTIVIRINAE; LENTIVIRUS INFECTION; MALE; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; PROSTATE; PROSTATE TUMOR; REPORTER GENE; TUMOR CELL LINE; VIROLOGY;

LENTIVIRUS;

ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINE, TUMOR; CLONE CELLS; EPITHELIAL CELLS; FLUORESCENCE; GENE SILENCING; GENES, REPORTER; GENETIC TECHNIQUES; GENETIC VECTORS; GLYCOPROTEINS; HUMANS; LENTIVIRUS; LENTIVIRUS INFECTIONS; MALE; PEPTIDES; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 77958089985     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.08.004     Document Type: Article

References (65)

1. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., Feuer E.J., Thun M.J. Cancer statistics, 2005. CA Cancer J. Clin. 2005, 55:10-30.
2. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
3. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994, 367:645-648.
4. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 2003, 100:3983-3988.
5. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., Conticello C., Ruco L., Peschle C., De Maria R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ. 2008, 15:504-514.
6. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
7. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
8. Ma S., Chan K.W., Hu L., Lee T.K., Wo J.Y., Ng I.O., Zheng B.J., Guan X.Y. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556.
9. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
10. Rutella S., Bonanno G., Procoli A., Mariotti A., Corallo M., Prisco M.G., Eramo A., Napoletano C., Gallo D., Perillo A., Nuti M., Pierelli L., Testa U., Scambia G., Ferrandina G. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clin. Cancer Res. 2009, 15:4299-4311.
11. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67:1030-1037.
12. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
13. Richardson G.D., Robson C.N., Lang S.H., Neal D.E., Maitland N.J., Collins A.T. CD133, a novel marker for human prostatic epithelial stem cells. J. Cell Sci. 2004, 117:3539-3545.
14. Trerotola M., Rathore S., Goel H.L., Li J., Alberti S., Piantelli M., Adams D., Jiang Z., Languino L.R. CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers of putative human prostate cancer stem cells. Am. J. Transl. Res. 2010, 2:135-144.
15. Miki J., Furusato B., Li H., Gu Y., Takahashi H., Egawa S., Sesterhenn I.A., McLeod D.G., Srivastava S., Rhim J.S. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res. 2007, 67:3153-3161.
16. Pfeiffer M.J., Schalken J.A. Stem cell characteristics in prostate cancer cell lines. Eur. Urol. 2009.
17. Tang D.G., Patrawala L., Calhoun T., Bhatia B., Choy G., Schneider-Broussard R., Jeter C. Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol. Carcinog. 2007, 46:1-14.
18. Wang X., Kruithof-de Julio M., Economides K.D., Walker D., Yu H., Halili M.V., Hu Y.P., Price S.M., Abate-Shen C., Shen M.M. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009, 461:495-500.
19. Yao M., Taylor R.A., Richards M.G., Sved P., Wong J., Eisinger D., Xie C., Salomon R., Risbridger G.P., Dong Q. Prostate-regenerating capacity of cultured human adult prostate epithelial cells. Cells Tissues Organs 2010, 191:203-212.
20. Collins A.T., Habib F.K., Maitland N.J., Neal D.E. Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J. Cell Sci. 2001, 114:3865-3872.
21. Hudson D.L., Guy A.T., Fry P., O'Hare M.J., Watt F.M., Masters J.R. Epithelial cell differentiation pathways in the human prostate: identification of intermediate phenotypes by keratin expression. J. Histochem. Cytochem. 2001, 49:271-278.
22. van Leenders G., Dijkman H., Hulsbergen-van de Kaa C., Ruiter D., Schalken J. Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy. Lab. Invest. 2000, 80:1251-1258.
23. Xue Y., Smedts F., Debruyne F.M., de la Rosette J.J., Schalken J.A. Identification of intermediate cell types by keratin expression in the developing human prostate. Prostate 1998, 34:292-301.
24. Logan A.C., Lutzko C., Kohn D.B. Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Curr. Opin. Biotechnol. 2002, 13:429-436.
25. Luther-Wyrsch A., Costello E., Thali M., Buetti E., Nissen C., Surbek D., Holzgreve W., Gratwohl A., Tichelli A., Wodnar-Filipowicz A. Stable transduction with lentiviral vectors and amplification of immature hematopoietic progenitors from cord blood of preterm human fetuses. Hum. Gene Ther. 2001, 12:377-389.
26. Qian H., Zhang X., Xu W., Zhu W., Cao H., Chen Y., Xu X., Wang M., Xie Y., Sun J. Lentivirus-modified human umbilical cord mesenchymal stem cells maintain their pluripotency. Biotechnol. Appl. Biochem. 2009.
27. Welm B.E., Dijkgraaf G.J., Bledau A.S., Welm A.L., Werb Z. Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer. Cell Stem Cell 2008, 2:90-102.
28. Consiglio A., Gritti A., Dolcetta D., Follenzi A., Bordignon C., Gage F.H., Vescovi A.L., Naldini L. Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc. Natl Acad. Sci. USA 2004, 101:14835-14840.
29. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272:263-267.
30. Kita-Matsuo H., Barcova M., Prigozhina N., Salomonis N., Wei K., Jacot J.G., Nelson B., Spiering S., Haverslag R., Kim C., Talantova M., Bajpai R., Calzolari D., Terskikh A., McCulloch A.D., Price J.H., Conklin B.R., Chen H.S., Mercola M. Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS ONE 2009, 4:e5046.
31. Schmeckpeper J., Ikeda Y., Kumar A.H., Metharom P., Russell S.J., Caplice N.M. Lentiviral tracking of vascular differentiation in bone marrow progenitor cells. Differentiation 2009, 78:169-176.
32. Hager S., Frame F.M., Collins A.T., Burns J.E., Maitland N.J. An internal polyadenylation signal substantially increases expression levels of lentivirus-delivered transgenes but has the potential to reduce viral titer in a promoter-dependent manner. Hum. Gene Ther. 2008, 19:840-850.
33. Hayward S.W., Dahiya R., Cunha G.R., Bartek J., Deshpande N., Narayan P. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell. Dev. Biol. Anim. 1995, 31:14-24.
34. Maitland N.J., Macintosh C.A., Hall J., Sharrard M., Quinn G., Lang S. In vitro models to study cellular differentiation and function in human prostate cancers. Radiat. Res. 2001, 155:133-142.
35. Gruh I., Wunderlich S., Winkler M., Schwanke K., Heinke J., Blomer U., Ruhparwar A., Rohde B., Li R.K., Haverich A., Martin U. Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors. J. Gene Med. 2008, 10:21-32.
36. Kim S., Kim G.J., Miyoshi H., Moon S.H., Ahn S.E., Lee J.H., Lee H.J., Cha K.Y., Chung H.M. Efficiency of the elongation factor-1alpha promoter in mammalian embryonic stem cells using lentiviral gene delivery systems. Stem Cells Dev. 2007, 16:537-545.
37. Staggers W.R., Paterson A.J., Kudlow J.E. Sequence of the functional human keratin K14 promoter. Gene 1995, 153:297-298.
38. Jain A., Lam A., Vivanco I., Carey M.F., Reiter R.E. Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene. Mol. Endocrinol. 2002, 16:2323-2337.
39. Watabe T., Lin M., Ide H., Donjacour A.A., Cunha G.R., Witte O.N., Reiter R.E. Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter. Proc. Natl Acad. Sci. USA 2002, 99:401-406.
40. Baird G.S., Zacharias D.A., Tsien R.Y. Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. Proc. Natl Acad. Sci. USA 2000, 97:11984-11989.
41. Ellis J., Yao S. Retrovirus silencing and vector design: relevance to normal and cancer stem cells?. Curr. Gene Ther. 2005, 5:367-373.
42. Imren S., Payen E., Westerman K.A., Pawliuk R., Fabry M.E., Eaves C.J., Cavilla B., Wadsworth L.D., Beuzard Y., Bouhassira E.E., Russell R., London I.M., Nagel R.L., Leboulch P., Humphries R.K. Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells. Proc. Natl Acad. Sci. USA 2002, 99:14380-14385.
43. Persons D.A., Hargrove P.W., Allay E.R., Hanawa H., Nienhuis A.W. The degree of phenotypic correction of murine beta-thalassemia intermedia following lentiviral-mediated transfer of a human gamma-globin gene is influenced by chromosomal position effects and vector copy number. Blood 2003, 101:2175-2183.
44. Li H., Chen X., Calhoun-Davis T., Claypool K., Tang D.G. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res. 2008, 68:1820-1825.
45. Hudson D.L., O'Hare M., Watt F.M., Masters J.R. Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells. Lab. Invest. 2000, 80:1243-1250.
46. Chapel-Fernandes S., Jordier F., Lauro F., Maitland N., Chiaroni J., de Micco P., Mannoni P., Bagnis C. Use of the PSA enhancer core element to modulate the expression of prostate- and non-prostate-specific basal promoters in a lentiviral vector context. Cancer Gene Ther. 2006, 13:919-929.
47. Cleutjens K.B., van der Korput H.A., van Eekelen C.C., van Rooij H.C., Faber P.W., Trapman J. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol. 1997, 11:148-161.
48. Greenberg N.M., DeMayo F.J., Sheppard P.C., Barrios R., Lebovitz R., Finegold M., Angelopoulou R., Dodd J.G., Duckworth M.L., Rosen J.M., et al. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol. Endocrinol. 1994, 8:230-239.
49. Kraaij R., van der Weel L., de Ridder C.M., van der Korput H.A., Zweistra J.L., van Rijswijk A.L., Bangma C.H., Trapman J. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors. Prostate 2007, 67:829-839.
50. [50] Lang, S., Anderson, E., Fordham, R., and Collins, A. Modelling the prostate stem cell niche: an evaluation of stem cell survival and expansion in vitro. Stem Cells Dev.
51. Swenson E.S., Price J.G., Brazelton T., Krause D.S. Limitations of green fluorescent protein as a cell lineage marker. Stem Cells 2007, 25:2593-2600.
52. Shaner N.C., Campbell R.E., Steinbach P.A., Giepmans B.N., Palmer A.E., Tsien R.Y. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat. Biotechnol. 2004, 22:1567-1572.
53. Liu H.S., Jan M.S., Chou C.K., Chen P.H., Ke N.J. Is green fluorescent protein toxic to the living cells?. Biochem. Biophys. Res. Commun. 1999, 260:712-717.
54. Xia X., Zhang Y., Zieth C.R., Zhang S.C. Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev. 2007, 16:167-176.
55. He J., Yang Q., Chang L.J. Dynamic DNA methylation and histone modifications contribute to lentiviral transgene silencing in murine embryonic carcinoma cells. J. Virol. 2005, 79:13497-13508.
56. Gerolami R., Uch R., Jordier F., Chapel S., Bagnis C., Brechot C., Mannoni P. Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors. Cancer Gene Ther. 2000, 7:1286-1292.
57. Mehta A.K., Majumdar S.S., Alam P., Gulati N., Brahmachari V. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice. Gene 2009, 428:20-24.
58. Tao W., Evans B.G., Yao J., Cooper S., Cornetta K., Ballas C.B., Hangoc G., Broxmeyer H.E. Enhanced green fluorescent protein is a nearly ideal long-term expression tracer for hematopoietic stem cells, whereas DsRed-express fluorescent protein is not. Stem Cells 2007, 25:670-678.
59. Williams S., Mustoe T., Mulcahy T., Griffiths M., Simpson D., Antoniou M., Irvine A., Mountain A., Crombie R. CpG-island fragments from the HNRPA2B1/CBX3 genomic locus reduce silencing and enhance transgene expression from the hCMV promoter/enhancer in mammalian cells. BMC Biotechnol. 2005, 5:17.
60. Robinson E.J., Neal D.E., Collins A.T. Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 1998, 37:149-160.
61. Swift S.L., Burns J.E., Maitland N.J. Altered expression of neurotensin receptors is associated with the differentiation state of prostate cancer. Cancer Res. 2010, 70:347-356.
62. Tran C.P., Lin C., Yamashiro J., Reiter R.E. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol. Cancer Res. 2002, 1:113-121.
63. Birnie R., Bryce S.D., Roome C., Dussupt V., Droop A., Lang S.H., Berry P.A., Hyde C.F., Lewis J.L., Stower M.J., Maitland N.J., Collins A.T. Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol. 2008, 9:R83.
64. Pfeiffer, M. J., and Schalken, J. A. Stem cell characteristics in prostate cancer cell lines. Eur Urol 57, 246-54.
65. Tang Y., Hamburger A.W., Wang L., Khan M.A., Hussain A. Androgen deprivation and stem cell markers in prostate cancers. Int. J. Clin. Exp. Pathol. 2009, 3:128-138.